ArticleBJC reports2025

Immune-related hepatic adverse events in renal cell carcinoma patients treated with immune checkpoint inhibitors: a retrospective study.

Amer Saleh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.